Remynd Nv Is A Biotechnology Company Located In Leuvenbelgiumfounded In 2002 As A Spin Off From The University Of Leuventhe Company Focuses On Developing Innovative Treatments For Neurodegenerative Diseasesparticularly Those Related To Protein Misfoldingit Has Received Significant Support From Grants In Belgium And Operates A Contract Research Organizationcrothat Specializes In Central Nervous System Disorders The Cro Provides Services To Clients Worldwideincluding In The Useuropeand Japanevaluating The Pharmacokineticspharmacodynamicsand Efficacy Of Experimental Treatments Using Proprietary Animal Modelsremynd Is Advancing Several Programsincluding An Alzheimerae S Program With An Investigational Compound Entering Phase 2A Clinical Trialsa Huntingtonae S Program Aimed At Restoring Brain Functionand A Discovery Program Targeting Mitochondrial Dysfunction In Amyotrophic Lateral Sclerosisals The Company Is Dedicated To Pioneering Effective Treatments That Aim To Restore And Preserve Neuronal Functioncontributing To A Healthier Future
